Official 2024 U.S. DOL Form 5500 summary for Value Drug Company (Value Drug Company 401(k) Profit-sharing Plan · EIN 23-1179140 · PN 001): $45.18M net assets, 218 active participants, and $24.22 per $10,000 (24.22 bps).
| Plan Sponsor | Value Drug Company |
|---|---|
| Filing Identifier | Value Drug Company 401(k) Profit-sharing Plan · EIN 23-1179140 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (PA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $45.18M |
| Active Participants | 218 |
| Direct Admin Fee Rate | $24.22 per $10,000 (24.22 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | CAPTRUST |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI